Xenophon Kassianides
General Practitioner with Extended Role in CVRM, Primary Care Cardiovascular Society,
The Ridings Medical Group, NHS Humber Health Partnership, Hull York Medical School
Xenophon is a General Practitioner with Extended Role in Cardiovascular-Renal-Metabolic (CVRM) Medicine, working with The Ridings Medical Group and NHS Humber Health Partnership. He holds an MD from Hull York Medical School and has completed postgraduate studies in Clinical Practice, Management, and Education with the University of Lancashire. He is a Member of both the Royal College of Physicians of Edinburgh and the Royal College of General Practitioners.
Xenophon's clinical and research focus is on CVRM conditions, with a particular interest in integrated care and prevention. He has served as Principal Investigator of the NIHR-adopted randomised controlled trial ExplorIRON-CKD and contributed to national research efforts, including the COVID-19 RECOVERY trial.
Xenophon is also a First5 GP Representative and Council Member of the Primary Care Cardiovascular Society (PCCS), where he leads the Society’s podcast production initiative, delivering accessible discussions on a wide range of cardiovascular topics for clinicians, academics, and healthcare professionals.
Passionate about academic medicine, Xenophon has an extensive publication record and has taught widely, holding lecturer positions with several UK medical schools. He continues to contribute actively to education as an Honorary Lecturer at Hull York Medical School and as a peer reviewer for leading scientific journals.